pozzilli kapp (11 Ergebnisse)

Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Autoimmunity, characterized by autoreactive lymphocytes and autoantibodies, is the consequence of a failure to discriminate between self and non-self, and autoimmune diseases are an increasing threat to people living in the industrialized countries. Autoimmune disorders are treatable, but not curable, and patients can face disability at later stages of the disease. Thus, there is a medical and economic need for new concepts and treatments in autoimmune disorders. New concepts and treatments can only be achieved by an interdisciplinary approach bringing together expertise, technologies, and clinical experience. The workshop focused on multiple sclerosis, rheumatoid arthritis and type I diabetes, and discussed conventional drug therapies, gene therapy, cell and tissue transplantation therapies, and first treatments using blood stem cells for reprogramming the patients' immune system.

gebundene Ausgabe, Leinen. with 17 Figures and 7 Tables, 135 pages abgegriffen, abgerieben, verschmutzt, fleckig, Kanten und Ecken bestossen, Seiten gebräunt, Stempel und Etikett auf Titelblatt und Einbandinnenseite vorne, kein Schutzumschlag, mittlerer bis eher guter Zustand, in Englisch Sprache: Englisch Ernst Schering Research Foundation Workshop Supplement 7.

Zustand: New. In.

Original-Pappband; 8°; XIII (I) 135 (11) Seiten. Sehr gutes Exemplar. Sprache: Englisch Ernst Schering Research Foundation Workshop Supplement 7. 360 gr.

Zustand: New. In.

Paperback. Zustand: Brand New. reprint edition. 135 pages. 8.00x5.75x0.25 inches. In Stock.

Hardcover. Zustand: Brand New. 1st edition. 139 pages. 8.25x6.00x0.50 inches. In Stock.

Taschenbuch. Zustand: Neu. New Concepts in Pathology and Treatment of Autoimmune Disorders | C. Pozzilli (u. a.) | Taschenbuch | Ernst Schering Foundation Symposium Proceedings | xiii | Englisch | 2013 | Springer | EAN 9783662044520 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Gebunden. Zustand: New. Autoimmunity, characterized by autoreactive lymphocytes and autoantibodies, is the consequence of a failure to discriminate between self and non-self, and autoimmune diseases are an increasing threat to people living in the industrialized countries. Autoimm.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Autoimmunity, characterized by autoreactive lymphocytes and autoantibodies, is the consequence of a failure to discriminate between self and non-self, and autoimmune diseases are an increasing threat to people living in the industrialized countries. Autoimmune disorders are treatable, but not curable, and patients can face disability at later stages of the disease. Thus, there is a medical and economic need for new concepts and treatments in autoimmune disorders. New concepts and treatments can only be achieved by an interdisciplinary approach bringing together expertise, technologies, and clinical experience. The workshop focused on multiple sclerosis, rheumatoid arthritis and type I diabetes, and discussed conventional drug therapies, gene therapy, cell and tissue transplantation therapies, and first treatments using blood stem cells for reprogramming the patients' immune system.

Buch. Zustand: Neu. Neuware - Autoimmunity, characterized by autoreactive lymphocytes and autoantibodies, is the consequence of a failure to discriminate between self and non-self, and autoimmune diseases are an increasing threat to people living in the industrialized countries. Autoimmune disorders are treatable, but not curable, and patients can face disability at later stages of the disease. Thus, there is a medical and economic need for new concepts and treatments in autoimmune disorders. New concepts and treatments can only be achieved by an interdisciplinary approach bringing together expertise, technologies, and clinical experience. The workshop focused on multiple sclerosis, rheumatoid arthritis and type I diabetes, and discussed conventional drug therapies, gene therapy, cell and tissue transplantation therapies, and first treatments using blood stem cells for reprogramming the patients' immune system.